These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7492105)

  • 81. Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis.
    Disney FA; Hanfling MJ; Hausinger SA
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S20-6. PubMed ID: 1513608
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin.
    Goscinski G; Tano E; Thulin P; Norrby-Teglund A; Sjölin J
    Scand J Infect Dis; 2006; 38(11-12):983-7. PubMed ID: 17148065
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antibiotic treatment of children with sore throat.
    Linder JA; Bates DW; Lee GM; Finkelstein JA
    JAMA; 2005 Nov; 294(18):2315-22. PubMed ID: 16278359
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
    Kaya EG; Yücel M; Karakoç AE
    Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis.
    Milatovic D; Knauer J
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):282-8. PubMed ID: 2496998
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis.
    Lennon DR; Farrell E; Martin DR; Stewart JM
    Arch Dis Child; 2008 Jun; 93(6):474-8. PubMed ID: 18337284
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarithromycin and azithromycin in Styria, Austria.
    Kriebernegg I; Feierl G; Grisold A; Marth E
    Zentralbl Bakteriol; 1998 Jan; 287(1-2):33-9. PubMed ID: 9532262
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.
    Schaad UB; Heynen G
    Pediatr Infect Dis J; 1996 Sep; 15(9):791-5. PubMed ID: 8878223
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an alternative to tonsillectomy?
    Orrling A; Stjernquist-Desatnik A; Schalén C
    Acta Otolaryngol; 1997 Jul; 117(4):618-22. PubMed ID: 9288223
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
    Tack KJ; Henry DC; Gooch WM; Brink DN; Keyserling CH
    Antimicrob Agents Chemother; 1998 May; 42(5):1073-5. PubMed ID: 9593129
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Randomized evaluation of benzathine penicillin V twice daily versus potassium penicillin V three times daily in the treatment of group A streptococcal pharyngitis. Pharyngitis Study Group.
    Kaufhold A
    Eur J Clin Microbiol Infect Dis; 1995 Feb; 14(2):92-8. PubMed ID: 7758493
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment Challenges of Group A Beta-hemolytic Streptococcal Pharyngo-Tonsillitis.
    Brook I
    Int Arch Otorhinolaryngol; 2017 Jul; 21(3):286-296. PubMed ID: 28680500
    [No Abstract]   [Full Text] [Related]  

  • 93. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.
    Dajani AS; Kessler SL; Mendelson R; Uden DL; Todd WM
    Pediatr Infect Dis J; 1993 Apr; 12(4):275-9. PubMed ID: 8483620
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it?
    Pichichero ME
    Pediatr Infect Dis J; 1993 Apr; 12(4):268-74. PubMed ID: 8483619
    [No Abstract]   [Full Text] [Related]  

  • 95. Macrolide and Clindamycin Resistance in Group a Streptococci Isolated From Children With Pharyngitis.
    DeMuri GP; Sterkel AK; Kubica PA; Duster MN; Reed KD; Wald ER
    Pediatr Infect Dis J; 2017 Mar; 36(3):342-344. PubMed ID: 27902646
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Common Questions About Streptococcal Pharyngitis.
    Kalra MG; Higgins KE; Perez ED
    Am Fam Physician; 2016 Jul; 94(1):24-31. PubMed ID: 27386721
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis.
    Schrock CG
    J Fam Pract; 1992 Dec; 35(6):622-6. PubMed ID: 1453146
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
    Jakob-Sölder B; Steininger C; Eigentler A; Allerberger F
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):811-2. PubMed ID: 9923529
    [No Abstract]   [Full Text] [Related]  

  • 99. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
    Sakran W; Raz R; Chazan B; Koren A; Colodner R
    Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Streptococcus pyogenes: in vitro susceptibility and role of beta-lactamase producing bacteria in the persistence of streptococcal pharyngotonsillitis].
    González Pedraza Avilés A; Ortiz Zaragoza MC
    Aten Primaria; 2000 May; 25(8):542-5. PubMed ID: 10876946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.